Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
July 1, 2026 9:00 AM EDT$100 million Transaction Follows Cumberland Shareholder Approval
Strengthens Cumberland's Focus on Rare Disease Pipeline
NASHVILLE, Tenn., July 1, 2026 /PRNewswire/ --Â Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a U.S. biopharmaceutical company, today announced the closing on an agreement with subsidiary of... More
